145 related articles for article (PubMed ID: 34232602)
1. Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.
Rowan DJ; Yasir S; Chen ZE; Mounajjed T; Erdogan Damgard S; Cummins L; Zhang L; Whitcomb E; Falck V; Simon SM; Singhi AD; Torbenson MS
Am J Surg Pathol; 2021 Aug; 45(8):1098-1107. PubMed ID: 34232602
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.
Yasir S; Chen ZE; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson MS
Am J Surg Pathol; 2022 Jun; 46(6):786-792. PubMed ID: 35383587
[TBL] [Abstract][Full Text] [Related]
4. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
5. Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas.
Salaria SN; Graham RP; Aishima S; Mounajjed T; Yeh MM; Torbenson MS
Am J Surg Pathol; 2015 Mar; 39(3):318-24. PubMed ID: 25602798
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Adenomas: Classification, Controversies, and Consensus.
Torbenson M
Surg Pathol Clin; 2018 Jun; 11(2):351-366. PubMed ID: 29751879
[TBL] [Abstract][Full Text] [Related]
8. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
[TBL] [Abstract][Full Text] [Related]
9. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.
Mounajjed T; Yasir S; Aleff PA; Torbenson MS
Mod Pathol; 2015 Sep; 28(9):1265-74. PubMed ID: 26205181
[TBL] [Abstract][Full Text] [Related]
10. Gene mutations in hepatocellular adenomas.
Raft MB; Jørgensen EN; Vainer B
Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.
Calderaro J; Nault JC; Balabaud C; Couchy G; Saint-Paul MC; Azoulay D; Mehdaoui D; Luciani A; Zafrani ES; Bioulac-Sage P; Zucman-Rossi J
Mod Pathol; 2016 Jan; 29(1):43-50. PubMed ID: 26516697
[TBL] [Abstract][Full Text] [Related]
12. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
14. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling.
Joseph NM; Blank A; Shain AH; Gill RM; Umetsu SE; Shafizadeh N; Torbenson MS; Kakar S
Hum Pathol; 2022 Apr; 122():60-71. PubMed ID: 35104461
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
20. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1alpha-mutated infracentimetic adenomatosis.
Laumonier H; Rullier A; Saric J; Balabaud C; Bioulac-Sage P
World J Gastroenterol; 2008 Aug; 14(30):4830-3. PubMed ID: 18720549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
